| Financial Year |
March 31 2023 |
| Monetary Funds |
145,500,751.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
266,830,870.99 |
| Advances to Suppliers |
3,016,384.97 |
| Other Receivables |
1,991,130.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
113,039,728.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,903,954.05 |
| Total Current Assets |
562,537,761.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
99,272.06 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
285,142,163.33 |
| Under-construction Projects |
144,576,677.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,585,966.87 |
| R&D expenses |
-- |
| Goodwill |
28,037,752.70 |
| Long-Term Deferred and Prepaid Expenses |
23,413,238.69 |
| Deferred Income Tax Assets |
5,006,762.68 |
| Other Non-Current Assets |
13,183,812.46 |
| Sub-Total of Non-Current Assets |
545,539,499.95 |
| Total Assets |
1,108,077,261.13 |
| Short-Term Loans |
59,035,052.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,505,077.88 |
| Accounts Payable |
145,973,995.57 |
| Accounts Received In Advance |
40,693.00 |
| Employee Compensation Payable |
9,410,702.05 |
| Taxes Payable |
14,129,248.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,363,167.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,871,905.65 |
| Other Current Liabilities |
7,345.00 |
| Sub-Total of Current Liabilities |
291,149,003.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,151,250.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,021,313.23 |
| Total Liabilities |
311,170,316.63 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
435,481,850.46 |
| Surplus Reserve |
14,555,419.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
265,898,636.29 |
| Minority Stockholder's Interest |
971,038.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
795,935,906.13 |
| Owner's Equity（Stockholder's Equity） |
796,906,944.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,108,077,261.13 |
